Lai Wang, President, Global Head of R&D at BeOne Medicines Ltd. (ONC), sold 1,068 shares at $276.74 ($296K) on 2026-06-23, disclosed to the SEC on 2026-06-25.
Open-market sale of $296k ONC by President, Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |
| ONC | SELL | 2025-07-31 | $1.6M | — | Filing → |